Polymarket Traders Bet SpaceX OpenAI Could Surpass Berkshire Hathaway on First Trading Day Drama Desk Awards Reshape Tony Awards Race Offering Potential Market Signals for Broadway Productions Tulsi Gabbard Resigns as US Director of National Intelligence Leadership Transition Could Influence National Security Policy Iran Could Open Strait of Hormuz Without Conditions as Part of Peace Deal Petraeus Indicates China Commerce Minister Skips APEC Opening Trade Representative Cites Urgent Official Business UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister Kimball Electronics Q1 2026 Earnings EPS Miss Drags Shares Lower First Citizens BancShares FCNCN Q1 2026 Earnings Preferred Stock Parent Reports Strong EPS Beat Shares Edge Higher Bowhead Specialty Holdings Inc Q1 2026 Earnings Strong EPS Beat Amid Modest Stock Decline RELL Q1 2026 Earnings EPS Beat Overshadowed by Weak Market Sentiment Talkspace Q1 2026 Earnings EPS Misses Estimates Significantly Stock Edges Higher RH Q1 2026 Earnings EPS Misses Estimates Stock Declines Amid Luxury Market Challenges Amphenol APH Surges 568 VolumeDriven Rally Tests Key Resistance RTX Dips 13 as Defense Sector Faces Headwinds Key Support Levels in Focus First Merchants Corporation FRME Slips Key Support Levels Tested After 115 Decline Jerash Holdings JRSH Edges Higher as Stock Holds Above Key Support Zone Senti Biosciences SNTI Holds Above Support Edges Higher Toward Key 106 Resistance TONX Q1 2026 Earnings Massive EPS Beat Drives 62 Stock Surge GPRK Q1 2026 Earnings Positive EPS of 036 Reported Amid Limited Visibility RIOT Q1 2026 Earnings EPS Lags Consensus by Wide Margin Stock Climbs 037 Despite Miss CION Q1 2026 Earnings EPS Misses Estimates by 174 Stock Declines MAC Q1 2026 Earnings BottomLine Miss Weighs on Investor Sentiment FGI Industries Ltd FGI Q1 2026 Earnings Strong EPS Beat Amid Challenging Environment Standard Chartered CEO Apologizes for Controversial Lower Value Human Capital Remark Equitable Holdings Inc EQH Q1 2026 Earnings Marginal EPS Miss as Stock Edges Higher Gain Therapeutics GANX Edges Higher as Shares Approach Key Resistance Level